Moreover, the current work showed that CPT administration could efficiently improve the hepatic functions and downregulate HCC markers indicated by the significant decrease of the serum levels of AFP after the second and third cycles of CPT compared to the baseline level. This evidence concerns the gene AFP and hepatocellular carcinoma.